Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Civica Rx has announced plans to build a 120,000 square-foot sterile injectable manufacturing facility in Petersburg, Virginia.
read more
Wednesday, December 18, 2019
Civica Rx and Hikma Pharmaceuticals announced imminent shipments of Heparin Sodium Injection, USP, and seven other essential injectable medicines.
read more
Wednesday, January 22, 2020
Civica Rx has signed a long-term agreement with Thermo Fisher Scientific to develop and manufacture medications with Civica as the owner of the regulatory pathway.
read more
Cipla has received final approval for its ANDA for Icatibant Injectable 30mg/3mL from the FDA.
read more
Cipla Limited announced its submission of an ANDA for Fluticasone propionate and Salmeterol inhalation powder (100/50 mcg, 250/50 mcg and 500/50 mcg) to the FDA.
read more
Tuesday, January 21, 2020
Cipher announced the Company received a Notice of Termination from Bausch Health in connection with the License, Development and Commercialization Agreement of Trulance.
read more
Friday, December 06, 2019
ChromaDex has announced the expansion of its partnership with Matakana Health (MHL) until early 2023, which will now include Australia in its territory.
read more
Tuesday, January 28, 2014
CPhI, part of UBM Live, has announced the appointment of Chris Kilbee to the role of Group Director of the UBM Pharma Portfolio. Central to the role is responsibility for the strategic development and delivery of market leading event brands CPhI, ...
read more
CPhI and UBM live, today announced that this year’s recent CPhI China 2013, which took place on 25th-27th June at the Shanghai New International Expo Centre, was the most successful exhibition to date.
read more
Chi-Med and BeiGene have entered into a collaboration agreement to evaluate two of Chi-Med’s drug candidates, surufatinib and fruquintinib, with BeiGene’s anti-PD-1 antibody tislelizumab, for solid tumor cancers.
read more
-- 100 Contract Research and Contract Manufacturing Organizations will be exhibiting at this year's September 17-19, 2013 Pharma ChemOutsourcing Show at the Jersey Shore reported Apaporis LLC, the organizer. The companies offer a wide range of ...
read more
Friday, December 20, 2013
Following a successful inspection by the German health authorities in July 2013 ChemCon received the approval required to manufacture semi-solid pharmaceuticals (gels and creams for topical therapy) for human use. This was an important step for the ...
read more
Tuesday, October 10, 2017
Protea Biosciences announced it plans to develop clinical screening assays in various areas of oncology.
read more
Celerion has announced the multimillion-dollar expansion of specialized pharmacies across their clinical research units in North America.
read more
Tuesday, February 18, 2014
Cedarburg Hauser Pharmaceuticals (CHP), an experienced contract
development and manufacturing organization (CDMO) specializing in small molecule APIs, has
announced the hire Alex Tretyakov, Ph.D. as its Director of Process Development.
read more